Search

Your search keyword '"Antoinette de Waha"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Antoinette de Waha" Remove constraint Author: "Antoinette de Waha"
36 results on '"Antoinette de Waha"'

Search Results

1. Prognostic impact of secondary prevention after coronary artery bypass grafting—insights from the TiCAB trial

2. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial

3. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial

4. Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials

5. Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials

6. Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

7. Coracoid impingement: current concepts

8. Impact of the Everolimus-Eluting Stent on Stent Thrombosis

9. Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials

10. A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease

11. Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction

12. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial

13. Everolimus-Eluting Versus Sirolimus-Eluting Stents A Meta-Analysis of Randomized Trials

15. Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial

16. TCT-230 Culprit Lesion Location and Outcome in Patients with Cardiogenic Shock Complicating Myocardial Infarction: A Substudy of the IABP-SHOCK II-Trial

17. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial

18. Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials

19. What is the evidence for IABP in STEMI with and without cardiogenic shock?

20. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

21. BIODEGRADABLE POLYMER DRUG-ELUTING STENTS VERSUS DURABLE POLYMER SIROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM THE ISAR-TEST 3, ISAR-TEST 4, AND LEADERS RANDOMIZED TRIALS AT 4 YEARS

22. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

23. Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials

24. Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials

25. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock

26. A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease

27. Ruptured versus stable plaques in human coronary arteries

28. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials

29. Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis

30. Abstract 2531: Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Diabetes Mellitus: Patient-Level Meta-Analysis of Randomized Trials

31. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence

32. TCT-673 Drug-eluting stents versus bare metal stents for saphenous vein graft lesions: meta-analysis of randomized trials

33. TCT-353 Long-Term Outcomes of Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 4 and LEADERS Randomized Trials

34. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials

35. Response to Letter Regarding Article, 'Stent Thrombosis with Everolimus-Eluting Stents: Meta-Analysis of Comparative Randomized Controlled Trials'

36. TCT-840 Clinical outcomes of patients treated with Nobori biolimus-eluting stent: meta-analysis of randomized trials

Catalog

Books, media, physical & digital resources